A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis

Annals of the Rheumatic Diseases

Volumn 58, Issue 2, 1999, Pages 96-102

  Hazenberg, Bouke P C ^a   Limburg, Pieter C ^a   Bijzet, Johan ^a   Van Rijswijk, Martin H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN;

ADIPOSE TISSUE; ADULT; AGED; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ASSAY; RHEUMATOID ARTHRITIS;

EID: 0032970366     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.2.96     Document Type: Article

References (26)

1. 1 Husby G. Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 1985;3:173-80.
2. 2 Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44-9.
3. 3 Janssen S, van Rijswijk MH, Meijer S, Ruinen L, van der Hem GK. Systemic amyloidosis: a clinical survey of 144 cases. Neth J Med 1986;29:376-85.
4. 4 Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991;70:246-56.
5. 5 Ahlmen M, Ahlmen J, Svalander C, Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol 1987;6:27-38.
6. 6 David J, Vouyiouka O, Ansell BM, Hall A, Woo P. Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol 1993;11:85-90.
7. 7 Berglund K, Thysell H, Keller C. Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol 1993;20: 2051-7.
8. 8 Janssen S, Elema JD, van Rijswijk MH, Limburg PC, Meijer S, Mandema E. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis. Appl Pathol 1985; 3:29-38.
9. 9 Linke RP, Gartner HV, Michels H. High-sensitivity diagnosis of AA amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits. J Histochem Cytochem 1995;43:863-9.
10. 10 Yakar S, Kaplan B, German G, Livneh A, Miura K, Shtrasburg S, et al. Quantification of tissue amyloid content in AA amyloidosis by inhibition ELISA. Amyloid: Int J Exp Clin Invest 1995;2:167-72.
11. 11 Westermark P. Diagnosing amyloidosis. [Editorial]. Scand J Rheumatol 1995;24:327-9.
12. 12 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper TsS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. 13 Westermark P. Diagnosis and characterization of systemic amyloidosis by biopsy of subcutaneous abdominal fat tissue. Internal Medicine Specialist 1984;5:154-60.
14. 14 Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355-63.
15. 15 Watanabe N, Kamei S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, et al. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem 1986;32:1551-4.
16. 16 Hazenberg BPC, Limburg PC, Bijzet J, van Rijswijk MH. Monoclonal antibody based ELISA for human SAA. In: Natvig JB, Førre Ø, Husby G, Husebekk A, Skogen B, Sletten K, et al, eds. Amyloid and amyloidosis 1990. Dordrecht: Kluwer Academic Publishers, 1981:898-901.
17. 17 Hazenberg BPC, Grond J, van den Top D, Bijzet J, Limburg PC, van Rijswijk MH. Detection of amyloid AA in rectal biopsies with a new monoclonal anti-human SAA antibody (Reu.86.2). [Abstract]. Kidney Int 1991;40:976-7.
18. 18 Poole S, Walker D, Gaines Das RE, Gallimore JR, Pepys MB. The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods 1998; 214:1-10.
19. 19 Hazenberg BPC, Limburg PC, Bijzet J, van Rijswijk MH. SAA versus CRP serum levels in different inflammatory conditions, studied by ELISA using polyclonal anti-AA and monoclonal anti-SAA antibodies. In: Isobe T, Araki S, Uchino F, Kito S, Tsubura E, eds. Amyloid and amyloidosis. New York: Plenum Press, 1988:229-33.
20. 20 Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol 1973;80:575-99.
21. 21 Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
22. 22 Westermark P, Stenkvist B, Natvig JB, Olding Stenkvist E. Demonstration of protein AA in subcutaneous fat tissue obtained by fine needle biopsy. Ann Rheum Dis 1979;38: 68-71.
23. 23 Kaplan B, German G, Pras M. Isolation and characterization of amyloid proteins using milligram amounts of amyloid-containing tissue. J Liquid Chrom 1993;16:2249-68.
24. 24 Orfila C, Giraud P, Modesto A, Suc JM. Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies. Hum Pathol 1986;17:366-9.
25. 25 Hawkins PN, Richardson S, Vigushin DM, David J, Kelsey CR, Gray RE, et al. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum 1993;36: 842-51.
26. 26 Hawkins PN. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci 1994;87:289-95.